Prevalence and characteristics of dermatological manifestations in COVID‐19 positive dermatologists: Report from a web‐based survey in India

Jakhar, Deepak; Das, Anupam; Kaul, Subuhi; Kaur, Ishmeet; Madke, Bhushan; Dalal, Ashish

doi:10.1111/jdv.17532

Cited by 2 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, the data from the Western world is showing quite a high association of skin lesions with COVID-19. However, data from South Asian countries like India is presenting a sharp contrast [16]. Among 1099 COVID-19 confirmed patients, only 0.2% presented with skin rash.…”

Section: Case Presentationmentioning

confidence: 98%

COVID-19 in a Dermatologist’s Clinic: A Case From Pakistan

Sharif¹,

Saleem²,

Mutti³

et al. 2021

Cureus

View full text Add to dashboard Cite

SARS-CoV-2 is a novel virus that is the causative agent of COVID-19. It can affect a variety of human organ systems, including the skin. Five clinical patterns of this infection have been described. These patterns not only help in diagnosing the disease but are also helpful in predicting the severity of infection. The percentage of dermatological manifestations of COVID-19 is highly variable in different regions of the world, with some western countries reporting the percentage as high as 20%. However, the data from Asia, especially Pakistan, in this regard is sparse. We report a case of COVID-19 infection (PCR proven) with maculopapular eruption. To our knowledge, this is the first case report of its kind being reported from Pakistan. We would encourage our fellow physicians to report more such cases so that the dermatological pattern of COVID-19 in Pakistan can be appropriately categorized in the literature.

show abstract

Section: Case Presentationmentioning

confidence: 98%

COVID-19 in a Dermatologist’s Clinic: A Case From Pakistan

Sharif¹,

Saleem²,

Mutti³

et al. 2021

Cureus

View full text Add to dashboard Cite

show abstract

Prevalence of cutaneous manifestations in COVID‐19: A meta‐analysis

Wen

et al. 2022

The Journal of Dermatology

View full text Add to dashboard Cite

The global epidemic of coronavirus disease 2019 (COVID‐19) endangers more and more people. Many studies on cutaneous manifestations related to COVID‐19 have emerged, but their prevalence has varied widely. The objective of this study was to conduct a meta‐analysis estimating the prevalence of skin manifestations in COVID‐19. Four databases PubMed, Web of Science, CBM, and CNKI were searched, and the results were screened by two reviewers. A random‐effects model was used to evaluate the overall prevalence. Heterogeneity was assessed by I 2 . Further subgroup analyses were conducted by region, sample size, sex, age, and severity of COVID‐19. A funnel plot and Egger's test were performed to assess publication bias. The pooled prevalence of cutaneous manifestation of 61 089 patients in 33 studies was 5.6% (95% confidence intervals [CI] = 0.040–0.076, I 2 = 98.3%). Severity of COVID‐19 was probably the source of heterogeneity. Studies with sample size <200 report higher prevalence estimates (10.2%). The prevalence of detailed types was as follows: maculopapular rash 2%, livedoid lesions 1.4%, petechial lesions 1.1%, urticaria 0.8%, pernio‐like lesions 0.5%, vesicular lesions 0.3%. Petechial lesions and livedoid lesions contain a higher proportion of severe patients than other skin manifestations. The prevalence rates of pernio‐like lesions, urticaria and petechial lesions vary greatly in different regions.

show abstract

Prevalence and characteristics of dermatological manifestations in COVID‐19 positive dermatologists: Report from a web‐based survey in India

Cited by 2 publications

References 9 publications

COVID-19 in a Dermatologist’s Clinic: A Case From Pakistan

COVID-19 in a Dermatologist’s Clinic: A Case From Pakistan

Prevalence of cutaneous manifestations in COVID‐19: A meta‐analysis

Contact Info

Product

Resources

About